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Abstract
 
Toll-like receptor (TLR) 4 is mainly found on cells of the myelopoietic lineage. It recognizes
lipopolysaccharide (LPS) and mediates cellular activation and production of proinflammatory
cytokines. Less is known about the distribution and role of TLR4 in epithelial cells that are
continuously exposed to microbes and microbial products. Here we show that the murine
 
small intestinal epithelial cell line m-IC
 
cl2 
 
is highly responsive to LPS and expresses both CD14
and TLR4. Transcription and surface membrane staining for CD14 were up-regulated upon
LPS exposure. Surprisingly, TLR4 immunostaining revealed a strictly cytoplasmic paranuclear
distribution. This paranuclear compartment could be identified as the Golgi apparatus. LPS
 
added to the supernatant was internalized by m-IC
 
cl2
 
 cells and colocalized with TLR4. Continu-
ous exposure to LPS led to a tolerant phenotype but did not alter TLR4 expression nor cellular
distribution. Thus, intestinal epithelial cells might be able to provide the initial proinflammatory
 
signal to attract professional immune cells to the side of infection. The cytoplasmic loca-
tion of TLR4, which is identical to the final location of internalized LPS, further indicates
an important role of cellular internalization and cytoplasmic traffic in the process of innate
immune recognition.
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Introduction
 
Exposure to LPS results in the immediate cell activation
and release of proinflammatory cytokines by macrophages.
This major cell wall constituent of Gram-negative bacteria
is one of the most potent inducers of an inflammatory re-
sponse and is responsible for the deleterious hemodynamic
dysregulation seen in patients with Gram-negative sepsis
(1). The serum protein, lipopolysaccharide binding protein,
catalyzes the transfer of LPS monomers from micelles to a
binding site on CD14, which in turn mediates the recogni-
 
tion of LPS through toll-like receptor (TLR)
 
*
 
 4 (2–4).
TLR4 belongs to a recently identified family of transmem-
brane proteins with a remarkably high similarity to immune
 
recognition receptors described in the fruit fly 
 
Drosophila
melanogaster
 
 (5). The LPS recognition complex consists of a
TLR4 homodimer together with MD-2, an extracellular
accessory LPS-binding protein (6). Activation initiates a cy-
toplasmic signaling cascade that ultimately leads to the deg-
 
radation of I
 
 
 
B, nuclear translocation of NF-
 
 
 
B, and tran-
scriptional activation of proinflammatory response genes
(7). The central role of CD14 and TLR4 during this pro-
cess in vivo is illustrated by the fact that deficient mice are
highly resistant to septic shock and that endotoxin hypore-
sponsiveness in humans is associated with genetic polymor-
phism in the TLR4 locus (8, 9).
Less is known about TLR4-mediated LPS recognition in
cells of epithelial surfaces, such as in the gastrointestinal
tract. The presence of a resident bacterial microflora and
high local concentrations of LPS should impede a similarly
susceptible detection system as seen in macrophages. In-
deed, low or absent expression of TLR4 and MD-2 was
shown in human colon carcinoma cell lines and LPS re-
sponsiveness could be enhanced by TLR4–MD-2 cotrans-
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doglycosidase H; MIP-2, macrophage inflammatory protein-2; nt., nucle-
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-glycosidase F; SLPI, secretory leukocyte pro-
tease inhibitor; TLR, toll-like receptor. 
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fection (10). Moreover, lack of CD14 expression was re-
cently reported in intestinal epithelial cells and isolated
intestinal macrophages (11, 12). The absence of the LPS
recognition complex therefore might explain the endo-
toxin hyporesponsiveness of the normal intestinal epithe-
lium to microbes and microbial products (13). However,
prominent enteric microbial pathogens such as 
 
Salmonella
 
,
specifically target the small intestine and evoke a rapid local
inflammatory response.
The number of established small intestinal cell systems
still remains limited. We therefore decided to use the re-
cently developed murine intestinal epithelial cell line m-IC
 
cl2
 
derived from L-PK/Tag1 transgenic mice as a model to
study LPS recognition in the small intestine (14). The sur-
prisingly sensitive phenotype to LPS stimulation led to a
careful study of the kinetic of cellular activation and the ex-
pression of molecules involved in LPS recognition, such as
CD14 and TLR4. Thus, we here propose a new model
for the process of TLR4-mediated LPS recognition in the
small intestine. The presence of LPS-sensitive epithelial
cells in the gastrointestinal tract raises important questions
about protective mechanisms to prevent inadequate host-
defense activation by exposure to luminal bacteria.
 
Materials and Methods
 
Antibodies and Reagents.
 
The rabbit anti-TLR4 antiserum was
raised against the synthesized polypeptide FQGIKLHELTL-
RGNFNSSNIMKTC that is located in the extracytoplasmic part
of the TLR4 protein (Innovagen) and affinity purified. Biotinyla-
tion of the anti-TLR4 antiserum was performed using EZ-Link
Sulfo-NHS-LC-Biotin (Pierce Chemical Co.) following the pro-
tocol of the manufacturer. Consequent purification was per-
formed using Microcon YM-10 centrifugal filter devices that
were purchased from Millipore. The goat anti-TLR4 peptide an-
tibody (sc-12511) was purchased from Santa Cruz Biotechnol-
ogy, Inc. This antibody was only used for immunofluorescence
studies and is called SC-12511 throughout this report. The rabbit
anti-CD14 antiserum (M-305) was obtained from Santa Cruz
Biotechnology, Inc. The murine monoclonal anti-Golgi 58K
protein (p58K) antibody was purchased from Sigma-Aldrich. The
polyclonal rabbit anti-
 
 
 
 coatomer protein 
 
(
 
COP) anti-serum was
purchased from Affinity Bioreagents, Inc. The monoclonal
CTR433 was a gift from Michel Bornens (Centre National de la
Recherche Scientifique, Gif-sur-Yvette, France) (15). The rat
monoclonal anti-murine TLR4-MD-2 antibody, MTS510, was a
gift from Kensuke Miyake (Department of Immunology, Saga
Medical School, Nabeshima, Saga, Japan) (16). 
 
Escherichia coli
 
 K12
D31m4 (Re) LPS was purchased from List Biological Laborato-
ries. Murine recombinant IL-1
 
 
 
 and TNF-
 
 
 
 as well as anti-mac-
rophage inflammatory protein-2 (MIP-2) and anti–TNF-
 
 
 
 anti-
bodies were obtained from Nordic BioSite. If not otherwise
stated, all reagents were purchased from Sigma-Aldrich.
 
Cell Culture.
 
RAW 264.7 cells were obtained from the
American Type Culture Collection and propagated in RPMI
1640 medium (GIBCO BRL) supplemented with 25 mM Hepes
and 
 
l
 
-glutamine. 10% FCS was added. m-IC
 
cl2
 
 cells were grown
in a modified hormonally defined FCS-supplemented (2%) me-
dium as previously described, and incubated at 37
 
 
 
C in a 5%
CO
 
2
 
–95% air atmosphere (14). Growth on collagen-coated cul-
ture plates was shown to induce apical–basolateral polarization
 
with tight junctions, which delineate the apical membrane do-
main as well as the apically located short microvili (14).
 
Cell Stimulation Assays.
 
Cells were grown on collagen-
coated culture plates using rat tail collagen type 1 (2 mg/ml), di-
luted 1:100 in ethanol/water (60:40 vol/vol). Culture plates or
flasks were rinsed and dried overnight. Cells were seeded and in-
cubated for 6 d with medium changes every second day. LPS was
vortexed, sonified for 15 min, and added to the cells at the ap-
propriate concentration. Cell supernatant was harvested after the
indicated incubation period and stored at 
 
 
 
20
 
 
 
C. Serum-free
cultivation of m-IC
 
cl2
 
 cells was performed in Episerf medium
(GIBCO BRL) for 12 d. As controls, cells were cultured in Epi-
serf medium supplemented with 2% FCS or in the original me-
dium (also containing 2% FCS). Cells were stimulated with LPS
at a concentration of 10 ng/ml with or without the addition of 2
 
 
 
g/ml recombinant CD14 (R&D Systems). The polarized secre-
tion of MIP-2 by m-IC
 
cl2
 
 cells was examined using transwell fil-
ters (Costar) as previously described (14). LPS stimulation was
performed selectively either on the apical (upper chamber) or the
basolateral (lower chamber) side of the cell layer. Restimulation
experiments were performed as follows: cells grown on collagen-
coated plates for 6 d were first exposed to LPS for 6 h, and then
washed and incubated for an additional 36 h in LPS-free me-
dium. Consequently, restimulation was performed with the indi-
cated concentrations of LPS, IL-1
 
 
 
 (100 ng/ml), or TNF-
 
 
 
 (50
ng/ml). Supernatants were harvested after 6 h and stored at
 
 
 
20
 
 
 
C.
 
ELISA.
 
IL-6 concentration in cell culture supernatant was
determined using the IL-6 Eli-pair ELISA kit obtained from Dia-
clone. MIP-2 and TNF-
 
 
 
 were measured using Nunc-Immuno
96-well plates (Nunc) coated with either polyclonal anti–MIP-2
(500 ng/ml) or monoclonal anti-TNF
 
 
 
 (3 
 
 
 
g/ml) capture anti-
body. Samples and serial dilutions of recombinant standard pro-
teins were coincubated with biotinylated polyclonal anti–MIP-2
(250 ng/ml) or monoclonal anti–TNF-
 
 
 
 (500 ng/ml) for 3 h at
room temperature. Consequently, plates were washed and incu-
bated with Streptavidin-HRP (Nordic Biosite). Substrate was
added and color development was quantified using a SpectraMax
Plus ELISA reader (Molecular Devices) at 450 nm.
 
Immunoblotting.
 
Cells were grown on collagen-coated 24-
well plates and stimulated with 10 ng/ml LPS. After 0, 20, and 40
min, the supernatant was removed and 200 
 
 
 
l lysis buffer (3:1
WB/SB vol/vol; SB: 250 mM Tris, pH 6.5, 8% SDS, 40% glyc-
erol; and WB: 50 mM Tris, pH 7.4, 120 mM NaCl) supple-
mented with protein-inhibitor cocktail (Roche Diagnostics) was
added. Cells were sonified for 10 min and lysates were frozen at
 
 
 
80
 
 
 
C until further use. Protein concentration was determined
(DC protein assay; Bio-Rad Laboratories) and 5-
 
 
 
g protein per
lane was separated on a 10% acrylamide gel. Proteins were blotted
on nitrocellulose and stained for phosphorylated I
 
 
 
B-
 
 
 
 (Ser32/
36) using a monoclonal anti–mouse antibody, and for the total
I
 
 
 
B-
 
 
 
 using a rabbit-polyclonal antibody (Cell Signaling Tech-
nology). For the detection of TLR4, m-IC
 
cl2
 
 cells were solubi-
lized in lysis buffer (3:1 WB/SB). Cell lysate was then separated
on an 8% SDS acrylamide gel. After the transfer on nitrocellulose,
filters were incubated with the anti-TLR4 antibody for 2 h at
room temperature followed by incubation with the peroxidase-
conjugated secondary antibody. To detect lectin binding, nitro-
cellulose filters were incubated with peroxidase-conjugated Con
A (Sigma-Aldrich) at a concentration of 1 
 
 
 
g/ml for 2 h at room
temperature. Staining was detected using the Renaissance chemi-
luminescence kit (NEN Life Science Products) in combination
with Hyperfilm ECL (Amersham Pharmacia Biotech). To re- 
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move N-linked carbohydrates, protein extracts were treated with
100 U/ml peptide 
 
N
 
-glycosidase F (PNGase F) derived from 
 
Fla-
vobacterium meningosepticum
 
 or endoglycosidase H (Endo H) de-
rived from 
 
Streptomyces plicatus
 
 (New England Biolabs, Inc.) for
1.5 h at 37
 
 
 
C as previously described (17).
 
Ribonuclease Protection Assay.
 
Total RNA was isolated using
TRIzol reagent (GIBCO BRL) and digested with DNase I (Am-
ersham Pharmacia Biotech). Fragments of the genes 
 
tlr4
 
 (nucle-
otide [nt.] 967–1286), 
 
tlr2
 
 (nt. 1291–1501), 
 
md-2
 
 (nt.12–289),
 
cd14
 
 (nt. 101–441), 
 
mip-2
 
 (nt. 629–764), 
 
slpi
 
 (nt. 19–199), 
 
gapdh
 
(nt 535–625), and 
 
l32
 
 (nt. 1331–1442) were amplified from mu-
rine cDNA (Expand Long Template PCR System; Roche Diag-
nostics) and cloned in PCR-Script SK (
 
 
 
) using the PCR-Script
Amp cloning kit according to the manufacturer’s protocol (Strat-
agene). The L32- and GAPDH-encoding RNA probes were
used as internal controls. Plasmids were linearized and 
 
32
 
P-labeled
anti-sense RNA probes were synthesized using the MAXIscript
in vitro transcription kit (Ambion). Hybridization and RNA di-
gest were performed according to the instruction manual of the
Riboquant RPA kit (BD PharMingen). RNA was purified and
separated on a 5% acrylamide/8 M urea gel and exposed over-
night to a PhosphorImager screen (Molecular Dynamics).
 
LPS Uptake Assay.
 
The Alexa Fluor 488–conjugated LPS
from 
 
E. coli
 
 O55:B5 (Molecular Probes) was preincubated in FCS
for 1 h and added to cells grown on collagen-coated Lab-Tek
chamber slides (Nunc) at a concentration of 100 ng/ml. After the
indicated incubation time, cells were fixed and stained for TLR4.
Alexa 594–conjugated anti–rabbit antibodies (Jackson Immu-
noResearch Laboratories) were used as secondary antibodies.
Narrow-band pass filters were used to avoid overlap in fluores-
cence of fluorophores.
 
Immunohistochemistry.
 
Cells were cultured on collagen-coated
Lab-Tek chamber slides (Nunc) for the indicated period, washed
with PBS, and air-dried. Slides were fixed in 50% ice-cold ace-
tone for 30 s and 100% ice-cold acetone for 5 min. Conse-
quently, an incubation in 0.3% H
 
2
 
O
 
2
 
 for 15 min in the dark was
performed. After washing, three blocking steps with 10% normal
goat serum, avidin, and biotin (Vector Laboratories) were per-
formed. The primary antibody was preincubated in 25% normal
mouse serum for 1 h at room temperature. Cells were then incu-
bated for 45 min with the primary antibody at a 1:100 dilution,
washed, and incubated with the biotinylated goat secondary anti-
body (Vector Laboratories) at a dilution of 1:200. After washing,
ABC ELITE reagent (Vector Laboratories) was added and incu-
bated for 30 min. Slides were then incubated in AEC substrate
(Vector Laboratories) until color development was sufficient.
Counterstaining was performed using Mayer’s hematoxylin and
slides were mounted in Kaiser’s gelatin solution.
 
Immunofluorescence Double Staining Procedure.
 
Cells were ace-
tone fixed and blocked with 10% normal serum derived from
the same species as the secondary antibody as described above.
The anti-TLR4 antiserum was preincubated in 25% normal
mouse serum and added to the cells for 45 min. Slides were
washed and incubated for 45 min with a Cy3-conjugated don-
key anti–rabbit secondary antibody (Jackson ImmunoResearch
Laboratories). Counterstaining was performed using Hoechst
33258 (DAPI) nuclear stain purchased from Pierce Chemical
Co. Finally, slides were mounted in Vectastain (Vector Labora-
tories) and analyzed under a Nikon Eclipse E400 microscope
(Global Medical Instrumentation) connected to a Hamamatsu
C4742–98 digital camera (Hamamatsu). Double immunofluo-
rescence staining was performed in four consecutive incubation
steps using FITC-conjugated donkey anti–mouse and TxR-
 
conjugated donkey anti–rabbit secondary antibodies (Jackson
ImmunoResearch Laboratories). The biotinylated anti-TLR4
antiserum was detected using TxR-conjugated streptavidin
(Jackson ImmunoResearch Laboratories). For the chase experi-
ment, cells were incubated with the anti-TLR4 antibody at 4
 
 
 
C
for 60 min. Cells were washed with ice-cold PBS and conse-
quently incubated at 37
 
 
 
C for 60 min. After fixation, the stain-
ing procedure was completed with a secondary TxR-conjugated
anti–rabbit antibody as described above. Control cells were in-
cubated with biotin-conjugated anti–H-2K
 
b
 
 antibodies (BD
PharMingen) at 4
 
 
 
C. TxR-conjugated streptavidin (Jackson Im-
munoResearch Laboratories) was added after 30 min to initiate
cross-linking of surface MHC molecules. Cells were washed in
ice-cold PBS and incubated at 37
 
 
 
C to facilitate internalization.
To deglycosylate cellular proteins, m-IC
 
cl2
 
 cells were incubated
with 100 U/ml PNGaseF or Endo H in the appropriate buffer
for 1 h at 37
 
 
 
C before and after acetone fixation. Successful de-
glycosylation of cellular proteins was verified by consequent in-
cubation with 0.2-
 
 
 
g/ml FITC-conjugated Con A (Sigma-
Aldrich) for 45 min at room temperature.
 
Isolation of Murine Intestinal Crypts.
 
C57BL/10ScSn and
C57BL/10ScN mice were purchased from Harlan Laboratories.
Animal experiments were approved by the Regional Animal
Ethical Committee (Stockholm, Sweden). Murine intestinal
crypts were isolated following a previously described protocol
(18). In brief, the small intestine of adult mice was removed and
rinsed with ice-cold Ca
 
2
 
 
 
- and Mg
 
2
 
 
 
-free PBS. Segments of in-
testinal tissue were then everted and incubated in 30 mM EDTA
in Ca
 
2
 
 
 
- and Mg
 
2
 
 
 
-free PBS for 20 min at 37
 
 
 
C. Consequently,
the tissue was carefully shaken to release the epithelial cell layer.
Crypts were then washed and purified by centrifugation at 700
 
 
 
g
 
.
 
Results
 
Secretion of Proinflammatory Mediators in Response to LPS.
 
Epithelial cells have long been considered to mainly act as
a physical barrier to protect the integrity of epidermal or
mucosal surfaces. A growing body of evidence now sug-
gests a more active role in host defense and a complemen-
tary function to professional immune cells such as macro-
phages. To analyze the LPS responsiveness of the small
intestinal epithelial cell line m-IC
 
cl2
 
, secretion of proin-
flammatory cytokine in response to endotoxin exposure
was determined and compared with the macrophage cell
line RAW 264.7. Whereas RAW 264.7 cells readily re-
sponded to small amounts of LPS with secretion of IL-6
and TNF-
 
 
 
, no such response was seen in epithelial cells
(unpublished data). However, evaluation of the production
of the chemokine MIP-2 revealed a fast and highly sensi-
tive response at concentrations as low as 0.01 ng/ml LPS
(Fig. 1
 
 
 
A). Although macrophages reached significantly
higher levels of total chemokine production, both the max-
imal stimulatory LPS concentration and the time kinetic of
MIP-2 secretion in m-IC
 
cl2
 
 cells and RAW 264.7 cells
were similar. Both cell types produced maximal MIP-2 se-
cretion at 1 ng/ml LPS (Fig. 1, A and C), and highest
chemokine productions were achieved after 6 h of stimula-
tion with LPS (Fig. 1, B and D). The rapid kinetic of cell
activation was further illustrated by an increase of phosphor-
ylated I
 
 
 
B-
 
 
 
 and consequent decrease of total I
 
 
 
B-
 
 
 
 after 
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20 min, followed by transcriptional up-regulation of MIP-2
after 45 min LPS stimulation (Fig. 1, E and F).
The differentiated and polarized phenotype of m-IC
 
cl2
 
cells was recently demonstrated (14, 19). The functional
apical-basolateral polarization was further illustrated by a
predominantly basolateral-directed secretion of MIP-2 by
m-IC
 
cl2
 
 cells grown on transwell filters (Fig. 1 G). These
data confirm the polarized phenotype of m-IC
 
cl2
 
 cells and
demonstrate the presence of a highly sensitive and rapid
mechanism of LPS recognition. However, macrophages
and epithelial cells seem to show distinct patterns of cyto-
kine response upon challenge.
 
CD14 Expression and Up-Regulation in Response to LPS.
 
The absence of CD14 expression in gastrointestinal tissue
was recently suggested to explain the unresponsive pheno-
type in respect to the normal intestinal flora (12, 13). Sur-
prisingly, CD14 expression was detected by ribonuclease
protection assay in m-IC
 
cl2
 
 cells, although at a significantly
lower level as RAW 264.7 cells (Fig. 2 A). Furthermore,
 
preincubation of epithelial cells with increasing amounts of
LPS significantly enhanced the level of CD14 mRNA ex-
pression. The relative amount of CD14 mRNA in m-IC
 
cl2
 
cells compared with RAW 264.7 cells was 
 
 1% in un-
treated cells, but increased to 14% at 100 ng/ml LPS and
21% at 10  g/ml LPS for 24 h. CD14 expression was con-
firmed by immunohistochemistry, demonstrating a weak
surface staining on untreated m-ICcl2 cells and an increas-
ingly intense staining signal after LPS exposure (Fig. 2 B).
The functional relevance of this autonomous CD14 pro-
duction was demonstrated by the preservation of the highly
LPS-susceptible phenotype of m-ICcl2 cells grown in the
absence of serum (Fig. 2 C). Thus, m-ICcl2 cells synthesize
CD14 and seem to enhance rather than diminish their
LPS-binding capacity in response to LPS exposure.
Analysis of TLR4 Expression in m-ICcl2 Cells and Isolated
Intestinal Crypt Epithelium. Although TLR4 might not di-
rectly bind LPS, it represents the sensor portion of the LPS
recognition complex indicated by chimeric transfection ex-
periments (20, 21). Expression of TLR4 as well as the ac-
cessory protein MD-2 was detected in epithelial m-ICcl2
cells by ribonuclease protection assay (Fig. 3 A). Interest-
ingly, the transcriptional levels of TLR4 and MD-2 did not
significantly differ from those found in the macrophage
RAW 264.7 cells. TLR2 transcription could also be dem-
onstrated in m-ICcl2 cells, suggesting that these cells recog-
nize a broader spectrum of microbial pattern molecules.
Immunohistochemistry using a polyclonal anti-TLR4
antibody revealed an intense cytoplasmic staining in both
m-ICcl2 and RAW 264.7 cells, which was readily blocked
by the addition of 10  g/ml of the peptide used for immu-
Figure 1. Comparison of MIP-2 secretion by m-ICcl2 cells and RAW
264.7 cells after LPS exposure. (A) Dose response after 6 h of incubation
for m-ICcl2 cells and (C) RAW 264.7 cells. (B) Time kinetic at 100 ng/
ml LPS concentration in cell supernatant of m-ICcl2 cells and (D) RAW
264.7 cells. All data are expressed as the mean of triplicate samples   SD
and are representative of three separate experiments. (E) Quantitative
analysis of total and phosphorylated (Ser32/36) I B-  in cell lysate 0, 20,
and 40 min after stimulation with 10 ng/ml LPS. (F) Transcriptional ex-
pression of mip-2 mRNA upon LPS exposure. m-ICcl2 cells were exposed
to 100 ng/ml LPS for the indicated time period (min) before cell lysis and
RNA extraction. Radioactively labeled mip-2– and gapdh-specific anti-
sense RNA probes were used in a ribonuclease protection assay. (G)
Comparison of apical versus basolateral MIP-2 secretion of LPS stimu-
lated m-ICcl2 cells cultured on transwell filters. LPS was added either at
the apical (upper chamber) or basolateral (lower chamber) side of the cell
layer. Results are expressed as the mean of triplicate samples   SD and
are representative of three separate experiments.
Figure 2. Transcriptional expression and immunostaining of m-ICcl2
cells for CD14. (A) Ribonuclease protection assay using specific antisense
probes for murine mRNA encoding CD14 and GAPDH. Before RNA
isolation, m-ICcl2 cells were exposed to 0.0, 0.1, or 10.0  g/ml LPS for 12 h.
RAW 264.7 cells were kept unstimulated. (B) Immunostaining for murine
CD14 on m-ICcl2 cells. Cells were incubated for 12 h in the presence of
various concentrations of LPS before fixation, as indicated. As control, im-
munostaining was performed on untreated cells by omitting the primary
antibody. Immunostaining was detected using the horseradish peroxidase
reaction and cells were counterstained with Mayer’s hematoxylin.  1,000.
(C) Comparison of MIP-2 secretion in response to LPS stimulation by
m-ICcl2 cells cultured in the presence or absence of serum. As control, 2
 g/ml recombinant CD14 was added before LPS stimulation.563 Hornef et al.
nization (Fig. 3 B). The overall signal intensity was more
pronounced in RAW 264.7 macrophages as compared
with m-ICcl2 cells. However, an exclusively perinuclear
staining pattern was seen in epithelial cells in contrast to the
somewhat more diffuse cytoplasmic staining seen in the
macrophage cell line.
The specificity of the antibody was confirmed using
bone marrow– and peritoneal-derived macrophages from
C57BL/10ScN mice, carrying a deletion of the Tlr4 lo-
cus. Staining was only detected in control cells derived
from wild-type C57BL/10ScSn mice (Fig. 3 C). Western
blot revealed a band of the predicted size of  96 kD (Fig.
3 D). In addition, a larger band of  120 kD was identified
similar to the recently described glycosylated form of hu-
man TLR4 (17). The identity of this larger band could be
confirmed by the binding of the lectin Con A and degra-
dation after enzymatic deglycosylation, using PNGase F
or Endo H (Fig. 3, D and E). The exclusively perinuclear
localization of TLR4 in m-ICcl2 cells was verified using
another antibody (sc12511), recognizing murine TLR4
(Fig. 3 F).
To further assess the relevance of TLR4 expression
found in m-ICcl2 cells, isolated crypt tissue from wild-type
C57BL/10ScSn and TLR4-deficient C57BL/10ScN mice
was examined (Fig. 3 G). Immunostaining revealed strong
expression of TLR4 by the crypt epithelium, whereas tis-
sue derived from C57BL/10ScN mice remained negative.
These data confirmed the presence of TLR4 expression in
murine small intestinal crypts in vivo and suggested that the
crypt epithelium may play a role in the detection of bacte-
rial microorganisms.
Identification of the Cytoplasmic TLR4-harboring Compart-
ment. The sharply defined perinuclear staining pattern
suggested that TLR4 is localized close to the Golgi appara-
tus. To better identify the cytoplasmic compartment har-
boring TLR4, double immunofluorescence studies were
performed using: (a) the monoclonal anti-Golgi 58K pro-
tein (p58K) antibody directed against the microtubule-
binding Golgi membrane protein 58K; (b) an anti– -COP
antibody recognizing one subunit of the COP I complex
involved in the regulation of retrograde transport between
the endoplasmic reticulum and the Golgi complex, as well
Figure 3. Analysis of TLR4 ex-
pression in m-ICcl2 cells and isolated
intestinal crypts. (A) Ribonuclease
protection assay using radioactively
labeled antisense RNA probes spe-
cifically hybridizing with murine
tlr4, md-2, tlr2, l32, and gapdh
mRNA. (B) Immunostaining for
murine TLR4 on RAW 264.7 cells
and m-ICcl2 cells. As control, the
primary antibody was incubated
with 10  g/ml of the peptide before
use for immunization.  1,000. (C)
Immunostaining of peritoneal mac-
rophages and bone marrow–derived
macrophages isolated from wild-type
C57BL/10ScSn and TLR4-deficient
C57BL/10ScN mice.  1,000. (D)
Western blot of m-ICcl2 cell lysate
revealing a band of the predicted
protein size of TLR4 at  96 kD
(arrow). In addition, a larger band at
 120 kD was found representing the
glycosylated form of TLR4 (arrow-
head). Overlay with Con A show-
ing binding to the larger band (ar-
rowhead). (E) The 120-kD band of
m-ICcl2 cell lysate stained with
TLR4 after treatment with Endo H
or PNGase F. (F) Comparison of
TLR4 staining in m-ICcl2 cells using
our TLR4 antibody and the TLR4
sc-12511 antibody. As control, the
peptide-blocked primary antibody,
or only the secondary antibody, was
used for TLR4 and sc-12511, re-
spectively. (G) TLR4 staining of iso-
lated murine small intestinal crypts.
Crypts were isolated from the small
intestine of C57BL/10ScSn and
TLR4-deficient C57BL/10ScN
mice.  400.564 Lipopolysaccharide Colocalizes with Toll-like Receptor 4 in the Golgi Apparatus
as intra-Golgi transport; and (c) the CTR433 antibody
binding to a yet uncharacterized antigen of the medium
compartment of the Golgi apparatus (22). All three mark-
ers of the Golgi complex p58K,  -COP, and CTR433
showed a clear colocalization with TLR4 staining, suggest-
ing a widespread distribution of TLR4 in the Golgi cister-
nae and the trans-Golgi network (Fig. 4 A). To confirm
that TLR4 is structurally connected to the Golgi apparatus,
we aimed to pharmacologically interfere with the structural
integrity of this compartment. Whereas brefeldin A induces
reversible translocation of the cis- to trans-Golgi complex
membranes to the endoplasmic reticulum, treatment with
nocodazole results in the vascularization and dispersion of
the Golgi complex because of disruption of the microtu-
bules. Pretreatment of cells with either nocodazole or
brefeldin A clearly affected the perinuclear pattern of TLR4
immunostaining (Fig. 4 B). A cytoplasmic punctuate stain-
ing morphology was found to be similar to what has been
described for TGN38 after brefeldin A treatment (23).
To exclude only temporary presence of TLR4 at the
identified location, pretreatment of epithelial cells with cy-
cloheximide, a potent inhibitor of eukaryotic protein syn-
thesis, was used. Temporary presence of TLR4 in the
Golgi apparatus would result in a continuously decreasing
staining intensity, because of a lack of newly synthesized
protein and an ongoing release of presynthesized mole-
cules from the Golgi apparatus. Protein inhibition could
disclose a possible final location of TLR4, visually ob-
scured by the strong perinuclear signal. However, pre-
treatment of cells with cycloheximide at 50  g/ml for 1.5
or 3 h did not result in a decreased staining signal (Fig. 4
C). In contrast, staining of cyclin B1, I B , or p53 almost
Figure 4. TLR4 staining in m-ICcl2 cells is lo-
calized to the Golgi apparatus. (A) Double immu-
nofluorescence of m-ICcl2 cells for TLR4 and
p58K,  -COP, or CTR433, which are all three
marker proteins of the Golgi apparatus. (B) Immu-
nofluorescence for TLR4 in m-ICcl2 cells after
pharmacological interference with the structural in-
tegrity of the Golgi apparatus. Cells were left un-
treated or preincubated with 10  M nocodazole,
or 5  g/ml brefeldin A for the indicated time pe-
riod before fixation. Note that perinuclear TLR4
staining begins to be concentrated again after 60
min because of the reversible effect and short half
life of brefeldin A. (C) TLR4 is permanently lo-
cated in the Golgi apparatus. Immunostaining of
TLR4 in m-ICcl2 cells after the inhibition of pro-
tein synthesis with cycloheximide (50  g/ml) for
1.5 and 3 h before fixation. As a control, cells were
stained with antibodies directed against cyclin B1, a
protein with a short half-life. (D) TLR4 is not in-
volved in retrograde membrane trans-Golgi net-
work traffic. The right part of the figure shows cells
incubated with the primary antibody for 2 h on ice
for chase experiments. After washing with ice-cold
PBS, cells were incubated at 37 C for 60 min,
fixed, and stained with the secondary fluorescence-
labeled antibody. To confirm cell viability, biotin-
labeled anti-MHC class I (H-2Kb) antibodies and
TxR-labeled streptavidin were used during primary incubation, inducing cross-linking and internalization of labeled MHC class I molecules. The left
part of the figure demonstrates complete staining of acetone-fixed cells as a control.  1,000. (E) Deglycosylation of m-ICcl2 cells in situ. Before staining
with TLR4 or Con A, cells were treated with Endo H or PNGase F.  1,000.565 Hornef et al.
disappeared during this time period, demonstrating the
high turnover of these molecules (unpublished data for
I B  and p53).
To examine the possibility of retrograde plasma mem-
brane trans-Golgi network traffic, a chase experiment with
incubation of the primary antibody at 4 C, washing with
ice-cold PBS, and continuous incubation at 37 C was per-
formed. Cells were fixed and stained with the secondary
antibody. In contrast to internalization of cross-linked
MHC class I molecules, no staining for TLR4 was detected
(Fig. 4 D). These data suggest that TLR4 permanently lo-
calizes to the Golgi apparatus of m-ICcl2 cells. They further
imply a rather long half-life of the TLR4 protein. To ex-
clude the possibility of a reduced affinity of the TLR4 anti-
body to maturely glycosylated TLR4, m-ICcl2 cells were
treated with Endo H or PNGase F before immunostaining
(Fig. 4 E). Deglycosylation with both enzymes resulted in a
significant reduction of Con A binding. However, no al-
teration of the staining distribution for TLR4 was detected.
LPS Uptake by m-ICcl2 Cells. Close physical proximity
between LPS and the TLR4 molecule was recently shown
to be required for recognition (20, 21). However, we
could not detect any membrane staining of TLR4 on
m-ICcl2 cells. Even cellular activation by LPS did not induce
surface staining of TLR4. Furthermore, all efforts to in-
hibit LPS-induced cell activation using the polyclonal anti-
TLR4 antiserum or the monoclonal anti–TLR4/MD-2
MTS510 antibody were unsuccessful (unpublished data).
We therefore speculated about the possibility of LPS up-
take and intracellular recognition by TLR4. Sonicated Al-
exa 488–conjugated LPS incubated with 10% FCS for 60
min was added to m-ICcl2 cells at 100 ng/ml. Fluorescence
could first be detected after 10–20 min of incubation and
showed a somewhat punctuated cytoplasmic appearance
(Fig. 5). To determine the cellular distribution of cytoplas-
mic LPS relative to the location of TLR4, Alexa 488–
LPS-exposed cells were fixed after various incubation
times, and stained for TLR4. Strikingly, fluorophorecon-
jugated LPS colocalized with TLR4 staining to a perinu-
clear cytoplasmic compartment after 10–30 min of incuba-
tion. These results suggested that the LPS recognition
event might not occur on the cell surface, but rather in a
cytoplasmic compartment.
Tolerance Induction in m-ICcl2 Cells. Protection from
continuous LPS stimulation is achieved in macrophages by
down-regulation of endotoxin responsiveness after primary
LPS exposure (24). This hyporesponsive phenotype has
been called tolerance. m-ICcl2 cells were exposed to 1  g/
ml LPS for 6 h, washed, and incubated for an additional
36 h in LPS-free medium. Reexposure was performed at
various LPS concentrations for 6 h and the MIP-2 con-
centration was determined in cell supernatant (Fig. 6 A).
Pretreatment at a concentration of 1  g/ml induced a
complete abrogation of the stimulatory activity of conse-
quent LPS exposure above the residual MIP-2 level result-
ing from the pretreatment. Even higher LPS concentrations
did not induce additional MIP-2 production. Interestingly,
pretreatment with LPS concentrations as low as 0.1 ng/ml
significantly inhibited subsequent cell activation. The max-
imal inhibitory effect was reached by pretreatment with
100 ng/ml LPS (Fig. 6 B). These data reflect the presence
of a sensitive but highly suppressive regulatory mechanism
to avoid LPS overstimulation in m-ICcl2 cells.
Localization of Reduced LPS Responsiveness in Tolerant
Cells. The diminished susceptibility of cells of the my-
elopoietic lineage to repeated LPS exposure was recently
proposed to be due to the down-regulation of TLR4 (25).
Therefore, transcription of TLR4 and MD-2 in m-ICcl2
cells was analyzed at different time points after exposure to
LPS. Probes detecting MIP-2 as well as TLR2 expression
were included as internal controls (Fig. 6 C). Furthermore,
secretory leukocyte protease inhibitor (SLPI), a protein re-
cently described to inhibit LPS-mediated cell activation,
was included (26). The high degree of cellular activation
through LPS was illustrated by an immediate up-regulation
of MIP-2 transcription. Interestingly TLR2 as well as SLPI
expression showed a marked temporary up-regulation sim-
ilar to the situation described in macrophages (26, 27).
However, no significant alteration of the transcription level
of TLR4 and MD-2 was found. Moreover, immunohis-
tochemistry revealed no significant change of the staining
intensity or the cellular distribution of TLR4 upon LPS ex-
posure (unpublished data). Therefore, down-regulation or
redistribution of TLR4 seems to not be involved in the de-
velopment of tolerance in m-ICcl2 cells. TLR4 and the re-
ceptor of IL-1  (IL-1R) share the main cytoplasmic signal-
ing pathway, whereas induction through the TNF- 
receptor is mediated via a different downstream cascade (7).
IL-1  and TNF-  induced significant secretion of MIP-2
in untreated m-ICcl2 cells. LPS pretreatment diminished the
susceptibility of IL-1  to a similar degree as seen for LPS
(P   0.01), whereas the chemokine response to TNF- 
was enhanced (Fig. 6 D). Collectively, these results locate
Figure 5. LPS is internalized in m-ICcl2 cells and colocalizes with
TLR4. m-ICcl2 cells were incubated for the indicated time periods with
Alexa-488–conjugated LPS, fixed, and immunostained for TLR4 using a
secondary Alexa 594–conjugated anti–rabbit antibody, as described in the
Materials and Methods section.  1,000.566 Lipopolysaccharide Colocalizes with Toll-like Receptor 4 in the Golgi Apparatus
the functional LPS hyporesponsiveness of tolerant m-ICcl2
cells downstream of TLR4.
Discussion
Enteric mucosal surfaces withstand constant exposure to
a great burden of bacteria and bacterial products, a prereq-
uisite for the intimate relationship between the host and its
beneficial normal microflora. Low or absent intestinal ex-
pression of molecules involved in LPS recognition intrigu-
ingly explains local endotoxin hyporesponsiveness (10–13).
However, here we describe a highly LPS-responsive phe-
notype of the murine small intestinal cell line m-ICcl2. Sig-
nificant levels of TLR4 and MD2 expression were found,
and even minute amounts of LPS led to rapid and pro-
nounced cell activation. In fact, the maximal stimulatory
LPS concentration and the kinetic of MIP-2 secretion were
found to be similar in m-ICcl2 cells and macrophage-like
RAW 264.7 cells. However, the response of m-ICcl2 cells
was limited to the production of the chemokine MIP-2.
No secretion of the proinflammatory cytokines TNF- , or
IL-6 was detected. Interestingly, m-ICcl2 cells expressed the
LPS coreceptor CD14. Although the basal level of CD14
expression was low, m-ICcl2 cells maintained full LPS sus-
ceptibility under serum-free conditions. Furthermore, LPS
exposure induced a dose-dependent increase leading to a
significant intensity of CD14-specific surface staining.
Hence, m-ICcl2 cells seem to be well equipped to respond
to LPS in order to initiate a proinflammatory response and
attract professional immune cells.
How can intact recognition of LPS be present in the
gastrointestinal tract without evoking proinflammatory
stimulation? Fetal enterocytes were shown to express
TLR4 and ex vivo–derived intestinal organ cultures from
fetal tissue demonstrated significantly higher LPS suscepti-
bility as compared with infant tissue (28, 29). Therefore,
down-regulation of endotoxin recognition only seems to
arise with microbial colonization of the intestine after
birth. It is noteworthy that few if any resident Gram-nega-
tive microflora were found in the small intestine (with the
exception of the terminal ileum) in contrast to the colon
(30). Interestingly, a recent thorough investigation of the
phenotypic markers of m-ICcl2 cells identified a number of
important properties and differentiated functions as found
in intestinal epithelial crypt cells. m-ICcl2 cells show a high
nucleus to cytoplasma ratio, rudimentary brush border, and
regular tight junctions that delineate the apical membrane
domain. They express glycoconjugates, polymeric immu-
noglobulin receptor, the cystic fibrosis transmembrane
conductance regulator, and the multidrug resistance-asso-
ciated protein MRP-1, which is characteristic of intestinal
crypt epithelium (14, 19). Although little is known about
the exact environmental conditions in the intestinal crypts
in vivo, recent work indicates that the local conditions
might differ significantly from the situation in the intestinal
lumen. High local concentrations of  -defensins along
with a permanent secretory flow might create a largely
bacteria-free environment in the enteric crypts of healthy
individuals (31). The LPS-neutralizing capacity of antimi-
crobial peptides could further diminish the local soluble
Figure 6. Transcriptional expression of
TLR4 is not altered in LPS-tolerant m-ICcl2
cells. (A) Pretreatment with LPS abrogates stim-
ulation to second LPS exposure, even at high
concentrations. m-ICcl2 cells were preincubated
at 1  g/ml LPS for 6 h, washed, and cultured
for an additional 36 h with LPS-free medium.
Restimulation was performed at 0.0 ng, 1.0 ng,
100.0 ng, or 10.0  g/ml LPS for 6 h, and MIP-2
concentration was determined in cell superna-
tant. (B) Minute amounts of LPS lead to a re-
duction of LPS susceptibility of m-ICcl2 cells.
Cells were preincubated for 6 h with 0.0, 0.1,
1.0, 10.0, or 100.0 ng/ml LPS. Restimulation
was performed with 100 ng/ml LPS for 6 h. (C) Transcription is not altered by LPS exposure. Ribonuclease protection assay from m-ICcl2 cells exposed
to 100 ng/ml or 5  g/ml of LPS for the indicated time period. Antisense RNA probes specifically hybridizing with tlr4, md-2, tlr2, slpi, mip-2, and gapdh
mRNA were used. (D) LPS tolerance is located downstream of TLR4. m-ICcl2 cells were pretreated with 1  g/ml LPS for 6 h and restimulation was
performed with 1 ng/ml LPS, 100 ng/ml IL-1 , or 50 ng/ml TNF- . All data are expressed as the mean of triplicate samples   SD and are representa-
tive of three separate experiments. Student’s t test was used for statistical analysis.567 Hornef et al.
LPS concentration (32). These exceptional conditions in
enteric crypts would allow the presence of an intact endo-
toxin recognition system. Indeed, crypts that are isolated
from murine small intestinal tissue showed a strong TLR4
expression. This is in accordance with the finding that hu-
man TLR4 expression in fetal small intestine was predom-
inantly found in crypt enterocytes (28). The fact that
prominent Gram-negative enteric pathogens specifically
target the small intestine might even demand the preserva-
tion of intact LPS recognition in this part of the gastrointesti-
nal tract. Tissue destruction by pathogenic microorganisms
would expose crypt cells to LPS and consequently initiate
an inflammatory response.
Surprisingly, immunostaining of m-ICcl2 cells revealed a
dense cytoplasmic perinuclear localization of TLR4. This
cytoplasmic compartment could be identified as the Golgi
apparatus using three independent markers. Pharmacolog-
ical disruption of the Golgi structure significantly altered
the TLR4 staining morphology, confirming the identified
location. No secondary cellular location or cycling be-
tween the cell surface and the Golgi complex could be
demonstrated as it was reported for TGN38 or the con-
vertase furin (23, 33). Thus, TLR4 of m-ICcl2 cells seems
to be permanently located in the Golgi apparatus. Interest-
ingly, the Golgi apparatus has previously been associated
with LPS-mediated cell activation (34, 35). In contrast to
m-ICcl2 cells, surface staining of TLR4 was detected on
nonpermeabilized murine peritoneal macrophages, using a
monoclonal anti-TLR4 antibody and FACS® analysis
(16). Moreover, TLR2 was demonstrated on the surface
of cells using transient transfection and a flag-based detec-
tion system (36). Consequently, internalization of zymo-
san particles was accompanied by the concentration of
TLR2 to phagosomes. Since peritoneal macrophages in
the healthy individual reside in a microbe-free environ-
ment, the localization of TLR4 on the plasma membrane
exposed to the surrounding environment might ensure the
highest LPS sensitivity. In contrast, the intracellular loca-
tion of TLR4 in epithelial cells would add an additional
regulatory barrier to prevent uncontrolled stimulation.
Similarly, an intracellular system of LPS recognition has
recently been suggested in intestinal epithelial cells (37).
However, further analysis of cellular TLR distribution in
intestinal tissue in vivo is clearly needed to validate the
importance of this finding.
Close physical contact between LPS and TLR4 was
clearly demonstrated to be necessary to mediate cell acti-
vation (20, 21). However, aside from the prominent para-
nuclear location, membrane staining of TLR4 was not de-
tected in m-ICcl2 cells. Chase treatment, protein synthesis
inhibition, and cell activation with LPS also did not reveal
any detectable surface membrane staining. Moreover, all
efforts to block TLR4-mediated signaling using an anti-
body directed against the TLR4–MD-2 complex failed,
although this strategy was successful in macrophages using
the same antibody (16). These results indicate that TLR4
is not on the plasma membrane of m-ICcl2 cells during
LPS-induced cell activation, but rather in an intracellular
compartment. The recent finding that oligomers of MD-2
associate with TLR4 in the endoplasmic reticulum–cis
Golgi network strengthens the hypothesis that the com-
plete LPS recognition complex might be present in the
Golgi compartment (38). Considering the highly LPS-
responsive phenotype, this exclusively intracellular loca-
tion of the LPS recognition complex strongly suggests that
internalization and transport of endotoxin is needed to fa-
cilitate close proximity between ligand and receptor at the
Golgi complex.
Indeed, uptake of fluorophore-conjugated LPS and cy-
toplasmic transport could be observed in m-ICcl2 cells.
Most importantly, endocytosed cytoplasmic LPS colocal-
ized to the TLR4-positive cellular compartment. Our data
therefore give an explanation for the recently described
transport of LPS to the Golgi compartment (34, 35). Inter-
nalization of LPS in the cytoplasm of several cell types has
been demonstrated in a number of studies (34, 35, 39–43).
Colocalization strategies could identify several intracellular
compartments. LPS was found in early endosomes, lyso-
somes, sarcomeres, and the Golgi apparatus (34, 35, 39,
40). Moreover, it seems that more than one way of LPS
uptake exists and the kind of internalization determines
both the consequences and the fate of the LPS (39, 41–44).
It was suggested that large aggregates of LPS are internal-
ized along with CD14 and deacylated via the lysosomal
pathway, whereas monomeric LPS is transported to the
Golgi apparatus and initiates cell activation (34, 43). In ad-
dition, the structure of LPS and the functional integrity of
TLR4 is at least indirectly implicated in this internalization
process (45, 46). The importance of LPS uptake for the
process of cell activation still remains controversial (40, 47).
However, an increasing body of evidence suggests that LPS
internalization is an obligatory event directly linked to rec-
ognition and cell activation in several cell types (38, 45, 46,
48, 49). We are currently evaluating the possible routes in-
volved in LPS internalization and their importance for sub-
sequent cell activation in our cell model.
After the initial signal that directs professional immune
cells to the site of infection, the release of proinflammatory
mediators needs to be controlled to avoid ongoing phago-
cyte infiltration and tissue damage. A negative regulator of
endotoxin-mediated cell activation is the serine protease
inhibitor SLPI, which inhibits LPS transfer to CD14, in-
ternalization, and prostaglandin synthesis (50, 51). Indeed,
intestinal m-ICcl2 cells showed a marked up-regulation of
SLPI upon LPS stimulation. Another mechanism to limit
the proinflammatory response might be the induction of
tolerance. Epithelial m-ICcl2 cells abrogated MIP-2 secre-
tion in response to LPS after endotoxin pretreatment. Re-
duction of LPS responsiveness was achieved by very low
amounts of LPS and could not be overcome even with
high concentrations of LPS. This reduced LPS susceptibil-
ity was recently found to coincide with the temporary
down-regulation of TLR4 after endotoxin exposure,
which suggests a regulatory role of TLR4 expression (25).
However, in m-ICcl2 cells neither the transcription of
TLR4 or MD-2, nor the total signal intensity or cytoplas-568 Lipopolysaccharide Colocalizes with Toll-like Receptor 4 in the Golgi Apparatus
mic distribution of TLR4 staining, was significantly altered
after LPS exposure. The preservation of susceptibility to
TNF- , but not to IL-1 , in tolerant cells suggested that
the cause of LPS hyporesponsiveness is located down-
stream of TLR4. These findings are in accordance with re-
cent reports describing induction of cross-tolerance by
ligands using different members of the TLR family, and
overexpression studies on tolerant Chinese hamster ovary
cells (52, 53).
In conclusion, we propose a model of intact LPS recog-
nition in small intestinal crypts to ensure immediate host-
defense activation upon microbial infection. Murine crypt
intestinal m-ICcl2 cells seem to be well equipped to recog-
nize LPS and show a highly sensitive phenotype. Continu-
ous LPS stimulation is inhibited by a sensitive and tight
state of tolerance, induced by inhibition of the cytoplasmic
TLR4 signaling pathway. TLR4 does not seem to be
present on the cell surface membrane, but instead resides at
high concentration in a cytoplasmic compartment, the
Golgi apparatus. LPS internalization and colocalization
with TLR4 indicates that LPS uptake represents an obliga-
tory step in the process of endotoxin recognition. Thus, we
present a novel model of the process of TLR4-mediated
LPS recognition in intestinal epithelial cells. The results
from this study provide, for the first time, an explanation to
the functional importance of LPS internalization and trans-
port to the Golgi complex. Membrane dynamics and cell
transport might therefore represent a novel level of regula-
tion of innate immune recognition, cell activation, and
host defense.
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